B

Bruker

Manufactures analytical instruments for NMR diagnostics

Sales Representative BBIO

Full-TimeUpdated on 10/14/2026Deadline 9/18/27
No salary listed
Senior
Bachelor's, Master's
Remote in Belgium
RemoteExtensive travel in the assigned territory is required.
Sales & Account ManagementField Sales

About the job

Requirements
  • A Bachelor's or Master's degree in Chemistry, Biology, Physics, or a related discipline is required.
  • At least 5 years of experience in scientific or technical equipment sales is required.
  • A valid passport and flexibility for extensive travel in the assigned territory are required.
  • A valid driver's license in good standing, issued by the resident state or governing location, is required.
  • Good knowledge of Magnetic Resonance products, including NMR and EPR, and their related applications is required.
  • Demonstrated success managing complex opportunities and negotiations is required.
  • Ability to work independently on routine tasks is required.
  • Ability to work independently on diverse-scope problems requiring evaluation of multiple factors and creative sales strategies is required.
  • Ability to manage moderately complex, high-visibility, or strategically important accounts is required.
  • Ability to enhance internal and external networks and advise others on difficult customer situations is required.
  • Ability to exercise independent judgment, with work reviewed at critical milestones, is required.
  • English, French, and Dutch are mandatory.
Responsibilities
  • Establish, develop, and maintain business relationships with current and prospective customers in the assigned region to generate new business for the NMR and EPR product lines.
  • Meet or exceed defined sales volume targets.
  • Qualify potential sales leads through discussions with customers, in person and remotely, and understand their needs.
  • Conduct telephone calls and in-person visits to communicate product offerings through presentations and other communication media.
  • Arrange product demonstrations with Product Specialists as necessary.
  • Produce clear and effective written proposals and quotations using company-provided quoting tools.
  • Maintain quoted prices within the predefined pricing matrix and negotiate contract terms and conditions within company guidelines.
  • Contribute to marketing activities such as advertisements and sales campaigns.
  • Attend exhibitions, seminars, and conferences locally and abroad.
  • Maintain up-to-date sales information in the company CRM, including leads, accounts, opportunities, and sales funnel management.
  • Focus attention on key accounts and provide feedback and competitive intelligence to marketing, sales, service, and others as appropriate.
  • Stay informed about product applications, technical services, market conditions, and competitive activities through multiple sources, including relevant documentation.
  • Maintain detailed knowledge of company and competitor products.
  • Find new customers in industry, academia, and governmental institutions using tools ranging from personal networking to internet searches.
  • Analyze territory trends, identify growth areas, and provide business reports and market analysis to Sales management.
  • Act as a Sales ambassador to support and train junior sales colleagues.
  • Support cross-selling initiatives.
  • Perform other duties as assigned that are broadly in line with the above objectives.

About the company

Bruker makes analytical and diagnostic instruments used by researchers and industries. Its products help analyze materials and biological samples to reveal chemical structure, composition, and properties, with notable roots in nuclear magnetic resonance (NMR) technology and a broad portfolio beyond that field. The company works by designing and selling instruments such as analytical tools that collect data from samples (for example, signals from nuclei in NMR or other spectroscopic methods) and provide insights to researchers. Bruker differentiates itself through a long history of developing advanced technologies, a focus on innovation in scientific instrumentation, and a global product range serving life sciences, materials science, and environmental analysis, supported by steady investment in research and development. Its goal is to equip researchers and industries with reliable tools to push the boundaries of what is possible in science and discovery.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Billerica, Massachusetts

Founded

1960

Get referred to Bruker

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • September 28, 2026 timsUltra AIP and timsOmni launches deepen proteomics and oligonucleotide workflows.
  • August 10, 2026 MIMETAS deal expands Bruker into human-relevant drug discovery models.
  • UC Berkeley ordered over $6 million of Bruker NMR systems, delivering 2027 revenue.

What critics are saying

  • Bruker’s first-half 2026 organic revenue declined 0.8%, exposing fragile demand recovery.
  • Academic spending stayed soft in 2026, while tariffs and currency pressured results.
  • If MIMETAS and fusion remain niche, Bruker’s acquisition-heavy strategy destroys capital returns.

What makes Bruker unique

  • Bruker owns timsTOF proteomics, NMR, microscopy, and microphysiological systems under one platform.
  • Bruker’s August 31 XFlash 7200 FIRE raises SEM-EDS throughput beyond conventional detector designs.
  • Bruker’s BEST superconductors supply ITER, Wendelstein 7-X, CERN, and fusion demonstrators.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

401(k) Retirement Plan

401(k) Company Match

Employee Stock Purchase Plan

Paid Vacation

Paid Sick Leave

Paid Holidays

Disability Insurance

Life Insurance

Dental Insurance

Flexible Work Hours

Employee Discounts

Growth & Insights and Company News

Headcount

6 month growth

13%

1 year growth

13%

2 year growth

13%
Business Wire
Oct 14th, 2026
Bruker Completes Acquisition of PhenomeX

Bruker Corporation (Nasdaq: BRKR) today announced that it has completed the acquisition of PhenomeX, a leading provider of single-cell biology research tools...

Financial Times
Sep 28th, 2026
Bruker advances functional proteomics with novel timsUltra AIP and timsOmni workflows for drug discovery & development and disease biology research.

Bruker advances functional proteomics with novel timsUltra AIP and timsOmni workflows for drug discovery & development and disease biology research. Sep 28 2026 12:00 BST * MultiDIA-PASEF significantly increases protein sequence coverage on timsUltra AIP * ProteoScape connects PASEF discovery with rapid prm-PASEF target validation * Spectronaut(R) AI transfer learning accelerates adaptation to new MS capabilities * Guided PASEF EXciD enables high-throughput glycopeptide characterization * Integrated HDX-MS workflows advance protein conformation and interaction studies * timsOmni(TM) enables RNA and DNA top-down structural and native RNA analysis SINGAPORE-(BUSINESS WIRE)-Sep. 28, 2026- At the Human Proteome Organization World Congress 2026, Bruker Corporation (Nasdaq: BRKR) today announced unique new timsUltra AIP and timsOmni workflows for deeper protein-sequence coverage, targeted validation, mobility-resolved glycopeptide characterization, structural proteomics, and oligonucleotide analysis. Multi-enzyme dia-PASEF provides additional peptide information for investigations of isoforms and proteoforms, while ProteoScape workflows connect PASEF discovery with prm-PASEF target validation on the same timsTOF platform. Novel timsOmni and integrated HDX-MS workflows extend structural analysis to glycopeptides, proteins, and nucleic acids.

MarketScreener
Sep 21st, 2026
Bruker Corporation receives order from University of California, Berkeley for high-field nmr systems for major upgrade of Magnetic Resonance research infrastructure.

Bruker Corporation receives order from University of California, Berkeley for high-field nmr systems for major upgrade of Magnetic Resonance research infrastructure. Published on 09/21/2026 at 09:36 am EDT S&P Capital IQ Bruker Corporation announced a multi-system order from University of California, Berkeley for high-field Nuclear Magnetic Resonance (NMR) instrumentation at the Pines Magnetic Resonance Center. The investment will enhance access to next-generation NMR technologies, including 800 MHz?class instrumentation. The investment is centered on a Bruker AV NEO-X 800 MHz spectrometer equipped with a cryogenically cooled MAS CryoProbe, complemented by several additional NMR systems and upgrades supporting solid-state, solution-state and Dynamic Nuclear Polarization (DNP) research. The UC Berkeley NMR order exceeds USD 6 million and is expected to be delivered in 2027. (C) S&P Capital IQ - 2026

U.S. Securities and Exchange Commission
Sep 19th, 2026
10-K

Market for Registrant’s Common Equity, Related Shareholder Matters and Issuer Purchases of Equity Securities

U.S. Securities and Exchange Commission
Sep 18th, 2026
10-Q

Unaudited Condensed Consolidated Balance Sheets as of June 30, 2024 and December 31, 2023